Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors (RIALTO)

This study has been terminated.
(Company decision has been taken in light of recent demands by certain national health authorities)
Information provided by:
Sanofi Identifier:
First received: April 6, 2007
Last updated: December 9, 2010
Last verified: December 2010
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)